Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the operating margin high or low?
The operating margin of 38.59% is in line with its 5-year average of 40.70%, near the high end of its 5-year range (-132.85%–53.15%).
0.13% below its 12-month average of 38.64%.
Reported quarterly operating margin; no daily interpolation.
OPERATING MARGIN
38.59%
OPERATING MARGIN AVG TTM
38.64%
OPERATING MARGIN AVG 3Y
39.39%
OPERATING MARGIN AVG 5Y
40.70%
OPERATING MARGIN AVG 10Y
32.73%
OPERATING MARGIN AVG 15Y
19.09%
OPERATING MARGIN AVG 20Y
-30.86%
CURRENT VS TTM AVG
-0.13%
CURRENT VS 3Y AVG
-2.04%
CURRENT VS 5Y AVG
-5.19%
CURRENT VS 10Y AVG
+17.90%
CURRENT VS 15Y AVG
+102.19%
CURRENT VS 20Y AVG
+225.05%
SECTOR MEDIAN · HEALTHCARE
14.90%
median of 90 covered companies
CURRENT VS SECTOR MEDIAN
+158.99%
vs the sector median at left
Vertex Pharmaceuticals Incorporated
Market Cap
$138.61B
Operating Margin
38.59%
TTM Avg
38.64%
3Y Avg
39.39%
5Y Avg
40.70%
Market Cap
$136.49B
Operating Margin
28.27%
TTM Avg
24.24%
3Y Avg
21.84%
5Y Avg
19.75%
Market Cap
$145.98B
Operating Margin
20.42%
TTM Avg
21.31%
3Y Avg
23.25%
5Y Avg
23.28%
Market Cap
$129.55B
Operating Margin
31.28%
TTM Avg
28.70%
3Y Avg
26.89%
5Y Avg
27.25%
Market Cap
$120.54B
Operating Margin
18.08%
TTM Avg
17.77%
3Y Avg
17.25%
5Y Avg
17.00%
Market Cap
$116.21B
Operating Margin
22.03%
TTM Avg
20.93%
3Y Avg
20.75%
5Y Avg
21.02%
Market Cap
$106.31B
Operating Margin
1.62%
TTM Avg
1.41%
3Y Avg
1.42%
5Y Avg
1.37%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Vertex Pharmaceuticals Incorporated (VRTX) | $138.61B | 38.59% | 38.64% | 39.39% | 40.70% |
| Bristol-Myers Squibb Company (BMY)vs › | $136.49B | 28.27% | 24.24% | 21.84% | 19.75% |
| Danaher Corporation (DHR)vs › | $145.98B | 20.42% | 21.31% | 23.25% | 23.28% |
| Intuitive Surgical, Inc. (ISRG)vs › | $129.55B | 31.28% | 28.70% | 26.89% | 27.25% |
| CVS Health Corp. (CVS)vs › | $123.43B | 2.00% | 2.43% | 2.79% | 3.48% |
| Medtronic plc (MDT)vs › | $120.54B | 18.08% | 17.77% | 17.25% | 17.00% |
| Stryker Corporation (SYK)vs › | $116.21B | 22.03% | 20.93% | 20.75% | 21.02% |
| Pfizer Inc. (PFE)vs › | $162.15B | 25.08% | 25.29% | 24.23% | 24.05% |
| McKesson Corporation (MCK)vs › | $106.31B | 1.62% | 1.41% | 1.42% | 1.37% |
| Sanofi (SNY)vs › | $106.23B | 14.74% | 18.46% | 19.67% | 22.87% |
Gross Margin
86.0%
Operating Margin
38.6%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | 37.41% |
| 2026-03-31 | 38.10% |
| 2025-12-31 | 40.30% |
| 2025-09-30 | 38.56% |
| 2025-06-30 | 38.83% |
| 2025-03-31 | 22.75% |
| 2024-12-31 | 35.23% |
| 2024-09-30 | 40.27% |
| 2024-06-30 | -132.85% |
| 2024-03-31 | 42.40% |
| 2023-12-31 | 39.26% |
| 2023-09-30 | 41.80% |
| 2023-06-30 | 41.17% |
| 2023-03-31 | 32.80% |
| 2022-12-31 | 44.88% |
| 2022-09-30 | 48.27% |
| 2022-06-30 | 50.37% |
| 2022-03-31 | 49.63% |
| 2021-12-31 | 42.35% |
| 2021-09-30 | 53.15% |
| 2021-06-30 | -2.11% |
| 2021-03-31 | 51.49% |
| 2020-12-31 | 45.82% |
| 2020-09-30 | 43.70% |
| 2020-06-30 | 47.10% |
| 2020-03-31 | 47.54% |
| 2019-12-31 | 39.02% |
| 2019-09-30 | 10.46% |
| 2019-06-30 | 28.68% |
| 2019-03-31 | 32.25% |
| 2018-12-31 | 14.68% |
| 2018-09-30 | 26.21% |
| 2018-06-30 | 22.98% |
| 2018-03-31 | 20.12% |
| 2017-12-31 | 19.30% |
| 2017-09-30 | -56.39% |
| 2017-06-30 | 9.69% |
| 2017-03-31 | 37.89% |
| 2016-12-31 | 8.64% |
| 2016-09-30 | -5.25% |
| 2016-06-30 | 0.78% |
| 2016-03-31 | -3.60% |
| 2015-12-31 | -13.28% |
| 2015-09-30 | -22.60% |
| 2015-06-30 | -103.06% |
| 2015-03-31 | -124.17% |
| 2014-12-31 | -106.27% |
| 2014-09-30 | -79.45% |
| 2014-06-30 | -130.64% |
| 2014-03-31 | -182.68% |
| 2013-12-31 | -78.07% |
| 2013-09-30 | -60.47% |
| 2013-06-30 | -18.32% |
| 2013-03-31 | -133.47% |
| 2012-12-31 | -23.20% |
| 2012-09-30 | -0.32% |
| 2012-06-30 | -2.57% |
| 2012-03-31 | 20.89% |
| 2011-12-31 | 39.75% |
| 2011-09-30 | 32.72% |
| 2011-06-30 | -144.98% |
| 2011-03-31 | -217.07% |
| 2010-12-31 | -254.31% |
| 2010-09-30 | -838.78% |
| 2010-06-30 | -536.25% |
| 2010-03-31 | -714.62% |
| 2009-12-31 | -432.94% |
| 2009-09-30 | -593.95% |
| 2009-06-30 | -824.42% |
| 2009-03-31 | -675.14% |
| 2008-12-31 | -432.36% |
| 2008-09-30 | -413.26% |
| 2008-06-30 | -131.80% |
| 2008-03-31 | -236.92% |
| 2007-12-31 | -179.93% |
| 2007-09-30 | -277.45% |
| 2007-06-30 | -328.88% |
| 2007-03-31 | -128.80% |
| 2006-12-31 | -37.06% |
| 2006-09-30 | -116.59% |
| 2006-06-30 | -266.51% |
| 2006-03-31 | -134.97% |
| 2005-12-31 | -41.40% |
| 2005-09-30 | -117.33% |
| 2005-06-30 | -119.41% |
| 2005-03-31 | -148.22% |
| 2004-12-31 | -101.51% |
| 2004-09-30 | -132.66% |
| 2004-06-30 | -227.79% |
| 2004-03-31 | -208.69% |
| 2003-12-31 | -1032.39% |
| 2003-09-30 | -464.53% |
| 2003-06-30 | -506.41% |
| 2003-03-31 | 84.95% |
| 2002-12-31 | -76.89% |
| 2002-09-30 | -104.60% |
